Vitiligo

Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study

August 30, 2022
Stay up to date with Aerolase!
Receive weekly newsletters, event & promotional alerts, and so much more!
By subscribing you agree to with our Privacy Policy and provide consent to receive updates from our company.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Share this webinar

Related posts

View all articles
Vitiligo
Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study

Read more
View all

See First-hand Aerolase's New Aging Solution

see moreschedule a demo

Interested in the Neo Elite®?

see moreschedule a demo

Interested in the Era Elite®?

see moreschedule a demo

Interested in the Exci308®?

see moreschedule a demo